financetom
Business
financetom
/
Business
/
Market Chatter: CoreWeave Won't Increase Offer for Core Scientific, CEO Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: CoreWeave Won't Increase Offer for Core Scientific, CEO Says
Oct 21, 2025 5:43 AM

08:09 AM EDT, 10/21/2025 (MT Newswires) -- CoreWeave ( CRWV ) will not increase its $9 billion offer for Core Scientific ( CORZ ) despite opposition from certain shareholders, Bloomberg News reported Tuesday, citing Chief Executive Officer Michael Intrator.

Some major Core Scientific ( CORZ ) shareholders believe the valuation is too low, according to the report.

CoreWeave ( CRWV ) and Core Scientific ( CORZ ) did not immediately respond to MT Newswires' request for comment on the matter.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Walt Disney's Pixar Unit Reportedly Cutting 14% of Workforce
--Street Color: Walt Disney's Pixar Unit Reportedly Cutting 14% of Workforce
May 21, 2024
11:17 AM EDT, 05/21/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 103.34, Change: +0.44, Percent...
Market Chatter: SEC Asks Nasdaq, CBOE, NYSE to Adjust Filings for Ether ETF Listing
Market Chatter: SEC Asks Nasdaq, CBOE, NYSE to Adjust Filings for Ether ETF Listing
May 21, 2024
11:17 AM EDT, 05/21/2024 (MT Newswires) -- Nasdaq (NDAQ), Cboe Global Markets ( CBOE ) and the New York Stock Exchange were asked by the US Securities and Exchange Commission to fine-tune listing applications for ether exchange-traded-funds, Reuters reported Tuesday, citing four people familiar with the process. Such requests from the SEC usually signal that the agency may be poised...
GT Biopharma Prices $3.2 Million Registered Direct Offering of Shares, Concurrent Private Placement of Warrants
GT Biopharma Prices $3.2 Million Registered Direct Offering of Shares, Concurrent Private Placement of Warrants
May 21, 2024
11:19 AM EDT, 05/21/2024 (MT Newswires) -- GT Biopharma ( GTBP ) said Tuesday it priced a registered direct offering of 740,000 common shares at $4.35 per share for expected gross proceeds of about $3.2 million. The company is also issuing warrants to purchase 740,000 shares with an exercise price of $4.35 per share in a concurrent private placement. The...
Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment
Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment
May 21, 2024
11:17 AM EDT, 05/21/2024 (MT Newswires) -- Durect ( DRRX ) said Tuesday it obtained the breakthrough therapy designation from the US Food and Drug Administration for larsucosterol to treat people with severe alcohol-associated hepatitis. The designation is backed by results from a phase 2b trial that assessed the safety and efficacy of larsucosterol, the company said. Durect ( DRRX...
Copyright 2023-2026 - www.financetom.com All Rights Reserved